Nanoparticles have garnered considerable interest in the field of antiviral therapeutics due to their unique properties and potential applications. Among these, cerium oxide (ceria) nanoparticles have shown promise as a novel antiviral agent, demonstrating durable, strong, and broadspectrum activity against RNA viruses. This paper explores the mechanism by which ceria nanoparticles target virion surfaces, leading to the inactivation of viral infectivity. By interfering with virus-receptor interactions, ceria nanoparticles disrupt crucial steps in the viral lifecycle, offering a promising avenue for the development of effective antiviral strategies.
HTML PDFShare this article
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report
